PERI

We had the opportunity to sell our Perion position this morning as the shares reacted to news of a $60 million buy back. Our sale price for $24.41. This netted $16,955. Owning Perion shares has been less than a pleasant experience. The shares are down more than 30% since we entered the position. We redeployed some of…

To access this post, you must subscribe.

Read More

Portfolio Updates

Confluent and Perion Yesterday two of our portfolio companies reported. One did well; the other result was a disappointment. At the moment, we are not taking any action on either stock in our high growth portfolio. That said, the forecast growth projected by Perion makes it difficult to hold in a high growth portfolio. On…

To access this post, you must subscribe.

Read More

Summary Perion, an adtech company, has been accused of fraudulent practices by Spruce Point, but the allegations are largely unfounded, according to the author.Despite a slowdown in advertising spend, Perion has seen demand re-acceleration in its latest quarter and its shares have risen by 90% over the past year.The company’s valuation remains modest, and it…

To access this post, you must subscribe.

Read More

We added 695 shares of Perion (PERI) to the high-growth model portfolio this morning at a price of $35.57. This cost $24, 730 and has taken our margin balance to $216,404, or about 28%at the value of the positions. Yesterday, we sold the remainder of our position in Trade Desk and I wanted to maintain…

To access this post, you must subscribe.

Read More